Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer

Biomedicine and Pharmacotherapy

Volumn 70, Issue C, 2015, Pages 19-23

  Tas, Faruk ^a   Tilgen Yasasever, Ceren ^a   Karabulut, Senem ^a   Tastekin, Didem ^a   Duranyildiz, Derya ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Diagnostic; Gastric cancer; IL 18; Predictive; Serum

Indexed keywords

CA 19-9 ANTIGEN; CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; INTERLEUKIN 18; LACTATE DEHYDROGENASE; ANTINEOPLASTIC AGENT; INTERLEUKIN 18 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOLID; STOMACH CANCER; TREATMENT RESPONSE; VERY ELDERLY; ADENOCARCINOMA; BLOOD; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; SIGNET RING CARCINOMA; STOMACH NEOPLASMS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SIGNET RING CELL; CASE-CONTROL STUDIES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 84927562725     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.12.040     Document Type: Article

References (8)

1. Kim K.E., Song H., Hahm C., Yoon S.Y., Park S., Lee H., et al. Expression of ADAM33 is a novel regulatory mechanism in IL-18-secreted process in gastric cancer. J Immunol 2009, 182:3548-3555.
2. Majima T., Ichikura T., Chochi K., Kawabata T., Tsujimoto H., Sugasawa H., et al. Exploitation of interleukin-18 by gastric cancers for their growth and evasion of host immunity. Int J Cancer 2006, 118:388-395.
3. Ye Z.B., Ma T., Li X., Jin X.L., Xu H.M. Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma. World J Gastroenterol 2007, 13:1747-1751.
4. Kang J.S., Bae S.Y., Kim H.R., Kim Y.S., Kim D.J., Cho B.J., et al. Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44. Carcinogenesis 2009, 30:1987-1996.
5. Kawabata T., Ichikura T., Majima T., Seki S., Chochi K., Takayama E., et al. Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma. Cancer 2001, 92:2050-2055.
6. Thong-Ngam D., Tangkijvanich P., Lerknimitr R., Mahachai V., Theamboonlers A., Poovorawan Y. Diagnostic role of serum interleukin-18 in gastric cancer patients. World J Gastroenterol 2006, 12:4473-4477.
7. Haghshenas M.R., Hosseini S.V., Mahmoudi M., Saberi-Firozi M., Farjadian S., Ghaderi A. IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers. J Gastroenterol Hepatol 2009, 24:1119-1122.
8. Matveeva L.V., Mosina L.M. Serum interleukin-18 level in precancerous conditions and gastric cancer. Eksp Klin Gastroenterol 2013, 6:21-24.